BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5788486)

  • 1. Quantitative measurements in female siblings and mothers of boys with Duchenne dystrophy.
    Fowler WM; Gardner GW; Taylor RG; Scavarda A; Busheikin JB
    Arch Phys Med Rehabil; 1969 Jun; 50(6):301-10. PubMed ID: 5788486
    [No Abstract]   [Full Text] [Related]  

  • 2. Duchenne's muscular dystrophy: the electrocardiogram in female relatives.
    Mann O; DeLeon AC; Perloff JK; Simanis J; Horrigan FD
    Am J Med Sci; 1968 Jun; 255():376-81. PubMed ID: 5654956
    [No Abstract]   [Full Text] [Related]  

  • 3. The detection of female carriers of pseudohypertrophic muscular dystrophy.
    Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
    Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
    Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex linked muscular dystrophies: severe and benign variety.
    Desai AD; Deshpande DH; Banerji AP; Jayam AV; Raju TN
    Neurol India; 1972 Dec; 20(4):163-89. PubMed ID: 4662748
    [No Abstract]   [Full Text] [Related]  

  • 6. [An unusual form of benign hereditary recessive x-chromosomal muscular dystrophy].
    Rotthauwe HW; Beyer H
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):410. PubMed ID: 5523692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of healthy relatives of patients with Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Hetnarska L; Emeryk B; Wasowicz B; Askanas W; Slucka C
    J Neurol Sci; 1968; 7(3):465-80. PubMed ID: 4974630
    [No Abstract]   [Full Text] [Related]  

  • 9. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
    Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
    [No Abstract]   [Full Text] [Related]  

  • 10. Disorder of muscle contraction processes in sex-linked (Duchenne) muscular dystrophy, with correlative electromyographic study of myopathic involvement in small hand muscles.
    Desmedt JE; Emeryk B
    Am J Med; 1968 Dec; 45(6):853-72. PubMed ID: 4235455
    [No Abstract]   [Full Text] [Related]  

  • 11. Carrier detection in the Duchenne type muscular dystrophy: preliminary observations on the place of electromyography.
    Jacobs K
    J Neurol Sci; 1968; 6(2):347-56. PubMed ID: 5707432
    [No Abstract]   [Full Text] [Related]  

  • 12. [Human embryonal muscles in Duchenne muscular dystrophy].
    Grinio LP
    Vopr Med Khim; 1990; 36(1):37-9. PubMed ID: 2343572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurogenic and myogenic hypotheses in human (Duchenne) muscular dystrophy.
    Thomson WH; Sweetin JC; Elton RA
    Nature; 1974 May; 249(453):151-2. PubMed ID: 4833513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 15. The manifesting carrier in Duchenne muscular dystrophy.
    Moser H; Emery AE
    Clin Genet; 1974; 5(4):271-84. PubMed ID: 4854942
    [No Abstract]   [Full Text] [Related]  

  • 16. Restricted forms of muscular dystrophy: a study of 11 cases.
    Mastaglia FL; Papadimitriou JM; Kakulas BA
    Proc Aust Assoc Neurol; 1969; 6():107-21. PubMed ID: 5349184
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum alpha-galactosidase activity in children with Duchenne-type muscular dystrophy and in gene carriers.
    László A; Havass Z
    Acta Paediatr Hung; 1983; 24(4):327-9. PubMed ID: 6324830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 20. Intellectual functioning in Duchenne muscular dystrophy: a review.
    Karagan NJ
    Psychol Bull; 1979 Mar; 86(2):250-9. PubMed ID: 382221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.